Frankfurt
22.11.24
08:05 Uhr
1,410 Euro
-0,070
-4,73 %
-4,73 %
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.11. | Nephros reports Q3 results | 1 | Seeking Alpha | ||
| NEPHROS Aktie jetzt für 0€ handeln | |||||
| 24.10. | Nephros, Inc.: Nephros Launches New HydraGuard 20" UltraFilter | 1 | GlobeNewswire (USA) | ||
| 18.10. | Nephros-Aktie stürzt auf 52-Wochen-Tief von 1,43 US-Dollar | 2 | Investing.com Deutsch | ||
| 18.10. | Nephros stock plunges to 52-week low of $1.43 amid market challenges | 1 | Investing.com | ||
| 17.10. | Nephros, Inc.: Nephros Delivers Critical Disaster Response to Support Hospitals and Care Facilities Impacted by Hurricanes Helene and Milton | 1 | GlobeNewswire (USA) | ||
| 09.10. | Nephros-Aktie fällt auf 52-Wochen-Tief von 1,45 US-Dollar | - | Investing.com Deutsch | ||
| 09.10. | Nephros stock plunges to 52-week low of $1.45 amid market challenges | 3 | Investing.com | ||
| 26.08. | NEPHROS INC - 8-K, Current Report | 1 | SEC Filings | ||
| 12.08. | Earnings call: Nephros reports mixed Q2 2024 results, focuses on digital tools | 1 | Investing.com | ||
| 08.08. | Nephros, Inc.: Nephros Announces Financial Results for Quarter Ended June 30, 2024 | 114 | GlobeNewswire (Europe) | Second-Quarter Net Revenue of $3.3 Million; New Accounts Help Drive Growth in Core Programmatic Business SOUTH ORANGE, NJ, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading... ► Artikel lesen | |
| 08.08. | NEPHROS INC - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 01.08. | Nephros, Inc.: Nephros Schedules Second Quarter 2024 Financial Results Conference Call | 2 | GlobeNewswire (USA) | ||
| 17.06. | NEPHROS INC - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 07.03. | Nephros, Inc.: Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results | 184 | GlobeNewswire (Europe) | Full-Year Net Revenue of $14.2 Million and Fourth-Quarter Net Revenue of $3.3 Million SOUTH ORANGE, NJ, March 07, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire - Nephros, Inc. (Nasdaq: NEPH), a leading... ► Artikel lesen | |
| 06.12.23 | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 06.12.2023 | 604 | Xetra Newsboard | The following instruments on XETRA do have their first trading 06.12.2023 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 06.12.2023
Aktien
1 US1468756044 Carver Bancorp Inc.
2... ► Artikel lesen |
15 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EMEIS | 5,254 | +0,63 % | emeis: Upturn in Performance Confirmed in Third-Quarter 2024 | Revenue up +8.3%, occupancy rate up +2.6 points
Regulatory News:
emeis (Paris:EMEIS):
Growth in all core activities and in all geographical areas (revenue and occupancy rate)
Solid... ► Artikel lesen | |
| NANO-X IMAGING | 6,350 | +3,08 % | Nano-X Imaging Ltd reports results for the quarter ended September 30 - Earnings Summary | ||
| BUTTERFLY NETWORK | 3,230 | -1,67 % | BFLY-Aktie erreicht 52-Wochen-Hoch bei 2,95 US-Dollar | ||
| GOODRX | 4,905 | +14,34 % | GoodRx Holdings one of the most undervalued stocks, Leerink says | ||
| TALKSPACE | 3,450 | +4,23 % | Espresa Partners with Talkspace to Boost Employee Well-Being with Accessible Mental Health Benefits | Espresa has partnered with Talkspace to expand mental health support for employees. Through Espresa's platform, clients now have access to Talkspace's 5,000+ licensed therapists, offering secure, on-demand... ► Artikel lesen | |
| CARMAT | 1,060 | +0,19 % | CARMAT's Aeson Artificial Heart Is Gradually Becoming a Reference Solution for Bridge to Transplant in Europe | Milestone of 30 heart transplants post Aeson® support, passed Strong interest in Aeson® from the medical community: more than 100 European experts will share their experience at the first... ► Artikel lesen | |
| JOINT CORP | 11,830 | +2,25 % | The Joint Corp. Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | SCOTTSDALE, Ariz., Oct. 15, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT) ("The Joint or "the Company"), the nation's largest franchisor of chiropractic care through The Joint Chiropractic®... ► Artikel lesen | |
| MIMEDX | 9,190 | -0,22 % | MIMEDX GROUP, INC. - 8-K, Current Report | ||
| HYPERFINE | 1,020 | +3,66 % | Hyperfine, Inc. Reports Third Quarter 2024 Financial Results | GUILFORD, Connecticut, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 93,60 | -0,90 % | PROCEPT BioRobotics Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance | SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BIOMERICA | 0,320 | -1,05 % | Biomerica secures patents for GI treatments in Europe | ||
| PROGYNY | 15,440 | +3,17 % | Progyny, Inc. Announces Third Quarter 2024 Results | Sales Season Yields Over 80 New Clients, 1.1 Million New Covered LivesSelected by a Leading National Health Plan and a Regional Health Plan as Their Preferred Partner1.5 Million Lives Adopt Newest... ► Artikel lesen | |
| ATRICURE | 35,730 | +0,08 % | Pre-market Movers: ASP Isotopes, NerdWallet, Reddit, AtriCure, Qorvo | OLATHE (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green ASP Isotopes Inc. (ASPI) is up over 44% at $8.33.
NerdWallet... ► Artikel lesen | |
| LIFEMD | 5,815 | +2,20 % | LifeMD, Inc.: LifeMD Reports Third Quarter 2024 Results | Total revenues increased 38% year-over-year to $53.4 million with telehealth revenue up 65%Record gross margin of 90.6%, up 300 basis points from the year-ago periodAdjusted EBITDA increased 33% to... ► Artikel lesen | |
| PROPHASE LABS | 0,705 | +2,17 % | ProPhase Labs, Inc.: ProPhase Labs Announces Positive Updates on Strategic Initiatives Company Anticipates Multiple Liquidity Events in H1 2025 | Projections for Pharmaloz Manufacturing: Approximately $16-17 Million in Revenue, $6-7 Million in Pre-Tax Earnings for 2025 Strategic Partnership Discussions Begin for BE-Smart Esophageal Cancer... ► Artikel lesen |
Das Unternehmen NEPHROS INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -4,73 % bei einem Aktienkurs von 1,410 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEPHROS INC finden Sie auf Wallstreet Online.
